Haoxi Health Technology Limited

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.

Haoxi Health Technology Limited trades as HAO on NASDAQ. The company is classified in Communication Services / Advertising Agencies and reports in USD.

The current profile places the business in Advertising Agencies. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $32.80M of revenue and $3.88M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Haoxi Health Technology Limited can be compared against peers such as Alliance Entertainment Holding Corporation, Anghami Inc., Baosheng Media Group Holdings Limited, Direct Digital Holdings, Inc., Everbright Digital Holding Limited Ordinary Shares, Harte Hanks, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $51,858, beta of -1.38, and return on equity of +22.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

HAO currently shows total debt of $1.99M and beta of -1.38. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 6-K (2026-06-04 00:00:00), 6-K (2026-05-21 00:00:00), 4 (2026-05-20 00:00:00), 6-K (2026-05-19 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.haoximedia.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.